- Hong Kong's new housing policies aim to lower down payments and increase development opportunities
- Elon Musk's Tesla crushes it
- PG&E to shut off power to reduce risk of sparking wildfires
- This billionaire NHL team owner is shutting down hedge fund
- Earnings season has reached 'maximum disorientation,' Jim Cramer says
This article was originally published on ETFTrends.com.
Biotechs ETFs created some heat yesterday as The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF, two popular exchange-traded funds tracking the biotechnology space, jumped on Monday after Pfizer, the largest drugmaker in the U.S., said it would buy Array BioPharma for over $10 billion. The iShares Nasdaq Biotechnology ETF (IBB) is on pace for its fourth positive day of […]
Continue Reading Below